In 2024, Progyny's return on assets (ROA) was 0.08, a 46.45% increase from the 0.06 ROA in the previous year.

Progyny Aktienanalyse

What does Progyny do?

Progyny Inc. is a company specializing in reproductive medicine and fertility treatments. It was founded in New York City in 2008 and has been listed on the NASDAQ stock exchange since 2019. The idea for Progyny arose when founder Gina Bartasi herself had difficulty getting pregnant and was searching for support and transparent information. She recognized the need to offer a better and more accessible service for people with fertility problems, thus founding Progyny. Progyny's business model is to offer employers a fertility benefit to help their employees, especially women, with family planning. It provides customized fertility treatments and financial assistance through its innovative programs. This allows employers to position themselves as progressive and inclusive while also increasing the bond and well-being of their employees. The different divisions of Progyny include fertility management, fertility measurement and monitoring, and fertility benefits. The fertility management solutions provide companies with comprehensive care for their employees, including counseling and support on fertility and family planning. They also provide access to an exclusive network practice specializing in reproductive medicine, including in vitro fertilization (IVF) and egg donation. The fertility measurement and monitoring program offers a personalized fertility profile that allows employees to track their fertility status to maximize their chances of a successful pregnancy. Progyny utilizes advanced methods of artificial intelligence and machine learning for this purpose. Progyny's fertility benefits include financial support for fertility treatments and medications that are not normally covered by health insurance. Additionally, the company offers a unique membership option that provides unlimited access to master fertility practices for one year. Progyny also offers a comprehensive patient experience through world-leading doctors and a patented technology platform. The platform provides support in navigating the fertility process and ensures that patients receive the best possible medical and financial care. Overall, Progyny has a significant impact on the field of reproductive medicine. With an innovative solution tailored to the needs of employers and strong support for aspiring parents, the company achieves a higher success rate in pregnancy compared to traditional fertility treatments. Progyny's technology platform improves workflow efficiency and communication in the practice, leading to a better patient experience and greater engagement. Overall, Progyny offers a holistic solution for employers and employees tailored to the unique challenges of family planning and fertility. With innovative approaches and a focus on the well-being of female employees, the company has taken a unique position in the market and is expected to continue to play a strong role in the industry. Progyny ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Progyny's Return on Assets (ROA)

Progyny's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Progyny's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Progyny's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Progyny’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Progyny stock

What is the Return on Assets (ROA) of Progyny this year?

The Return on Assets (ROA) of Progyny is 0.08 undefined this year.

What was the ROA of Progyny compared to the previous year?

The ROA of Progyny has increased by 46.45% compared to the previous year.

What consequences do high ROA have for investors of Progyny?

A high ROA is advantageous for investors of Progyny, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Progyny?

A low ROA can be unfavorable for investors of Progyny as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Progyny affect the company?

An increase in ROA of Progyny can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Progyny impact the company?

A reduction in the ROA of Progyny can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Progyny?

Some factors that can influence the ROA of Progyny include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Progyny important for investors?

The ROA of Progyny is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Progyny take to improve ROA?

To improve ROA, Progyny can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Progyny pay?

Over the past 12 months, Progyny paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Progyny is expected to pay a dividend of 0 USD.

What is the dividend yield of Progyny?

The current dividend yield of Progyny is .

When does Progyny pay dividends?

Progyny pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Progyny?

Progyny paid dividends every year for the past 0 years.

What is the dividend of Progyny?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Progyny located?

Progyny is assigned to the 'Health' sector.

Wann musste ich die Aktien von Progyny kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Progyny from 12/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did Progyny pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of Progyny in the year 2023?

In the year 2023, Progyny distributed 0 USD as dividends.

In which currency does Progyny pay out the dividend?

The dividends of Progyny are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Progyny

Our stock analysis for Progyny Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Progyny Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.